Accordingly, the present study aimed to determine the metabolic effects of FABP3 on transverse aortic constriction (TAC)-induced cardiac hypertrophy and heart failure using genetic mutant Fabp3-null mice. The gene discussed is FABP3; the disease is heart failure.